SG Americas Securities
BCAB icon

SG Americas Securities’s BioAtla BCAB Stock Holding History

SG Americas Securities’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-261
Closed -$45K – 2859
2024
Q1 		$45K Sell
261
-192
-42% -$23.9K ﹤0.01% 2783
2023
Q4 		$56K Buy
453
+14
+3% +$1.21K ﹤0.01% 2900
2023
Q3 		$37K Buy
+439
New +$56K ﹤0.01% 2987
2022
Q2 		– Sell
-270
Closed -$68K – 3413
2022
Q1 		$68K Buy
270
+168
+165% +$70.3K ﹤0.01% 2813
2021
Q4 		$100K Sell
102
-18
-15% -$23K ﹤0.01% 3086
2021
Q3 		$177K Buy
+120
New +$234K ﹤0.01% 3312
2021
Q1 		– Sell
-236
Closed -$401K – 3281
2020
Q4 		$401K Buy
+236
New +$394K ﹤0.01% 2153

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

SG Americas Securities's BCAB Position: Q2 2024 in Review

SG Americas Securities sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 261 shares — an estimated $45K sold.

SG Americas Securities first reported a position in BCAB in Q4 2020 and held it in 7 quarters. The position peaked at $401K in Q4 2020. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • SG Americas Securities reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • SG Americas Securities sold 261 BioAtla shares in Q2 2024, an estimated $45K.
  • SG Americas Securities first reported a position in BioAtla in Q4 2020 and held it in 7 quarters.
  • SG Americas Securities's BioAtla position peaked at $401K in Q4 2020.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.